Pfizer Inc. (PFE)

32,10 -0,30 (-0,93%) Al cierre: 04:02PM EDT

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(es): Healthcare
Sector: Drug Manufacturers—General
Empleados a tiempo completo: 83.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Albert Bourla D.V.M., DVM, Ph.D.	Chairman & CEO	11,72M	N/A	1962
Mr. Frank A. D'Amelio	CFO & Exec. VP	N/A	N/A	1958
Mr. David M. Denton	Chief Financial Officer & Exec. VP	18,19M	N/A	1965
Dr. Mikael Dolsten M.D., Ph.D.	Chief Scientific Officer and Pres of R&D	5,82M	N/A	1958
Ms. Angela Hwang	Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.	4,89M	7,7M	1966
Ms. Jennifer B. Damico	Sr. VP, Controller & Principal Accounting Officer	N/A	N/A	1968
Ms. Lidia L. Fonseca	Exec. VP and Chief Digital & Technology Officer	N/A	N/A	1969
Mr. Christopher J. Stevo CFA	Sr. VP & Chief Investor Relations Officer	N/A	N/A	N/A
Mr. Douglas M. Lankler	Exec. VP & Gen. Counsel	N/A	N/A	1966
Mr. Rady A. Johnson	Exec. VP and Chief Compliance, Quality & Risk Officer	N/A	N/A	1962

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Gobierno corporativo

El ISS Governance QualityScore de Pfizer Inc., a día 1 de septiembre de 2023, es 5. Las puntuaciones base son Auditoría: 10; Tablero: 5; Derechos de los accionistas: 1; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.